par Awada, Ahmad
;Giacchetti, S;Gérard, B.;Eftekhary, P;Lucas, Catherine;de Valeriola, Dominique
;Poullain, M G;Soudon, J;Dosquet, C;Brillanceau, M-H;Giroux, B;Marty, Marianne;Bleiberg, Harry
;Calvo, F;Piccart-Gebhart, Martine 
Référence Annals of oncology, 13, 12, page (1925-1934)
Publication Publié, 2002-12




Référence Annals of oncology, 13, 12, page (1925-1934)
Publication Publié, 2002-12
Article révisé par les pairs
Titre: |
|
Auteur: | Awada, Ahmad; Giacchetti, S; Gérard, B.; Eftekhary, P; Lucas, Catherine; de Valeriola, Dominique; Poullain, M G; Soudon, J; Dosquet, C; Brillanceau, M-H; Giroux, B; Marty, Marianne; Bleiberg, Harry; Calvo, F; Piccart-Gebhart, Martine |
Informations sur la publication: | Annals of oncology, 13, 12, page (1925-1934) |
Statut de publication: | Publié, 2002-12 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Biological Availability | |
Carbazoles -- administration & dosage | |
Carbazoles -- adverse effects | |
Carbazoles -- pharmacokinetics | |
Dose-Response Relationship, Drug | |
Drug Administration Schedule | |
Ellipticines | |
Female | |
Follow-Up Studies | |
Humans | |
Infusions, Intravenous | |
Male | |
Maximum Tolerated Dose | |
Middle Aged | |
Neoplasms -- drug therapy | |
Neoplasms -- pathology | |
Pyridines -- administration & dosage | |
Pyridines -- adverse effects | |
Pyridines -- pharmacokinetics | |
Risk Assessment | |
Sensitivity and Specificity | |
Treatment Outcome | |
Note générale: | Clinical Trial |
Clinical Trial, Phase I | |
Journal Article | |
Multicenter Study | |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:doi/10.1093/annonc/mdf321 | |
info:scp/0036920041 | |
info:pmid/12453862 |